Loading product details…Cargando detalles del producto…Carregando detalhes do produto…

At a glance

AGORESEARCH
Specification
Category
Form
Knowledge source
Research focus
Reconstitution
Storage
COA

What is SK10?

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human studies have examined anxiety-related clinical measures, leu-enkephalin metabolism, EEG response patterns, and functional brain connectivity after Selank exposure. Intranasal drops or solution are the delivery methods reported in the primary human research summarized on this page.

The vial calculation is concentration based. Dividing 10,000 mcg by the measured final volume gives mcg per mL. Multiplying that concentration by the verified pump output gives mcg per spray

Research context

5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Research

Reference literature focus

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human Selank research has primarily used the intranasal route. Quick reference for the intranasal Selank 10 mg calculation. Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Dosing & Protocol

LPPeptide handling reference

Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Storage

Registered 0.15% product: Protected from light, stored at no more than 10 degrees C, and not frozen. Opened registered product: The manufacturer permits storage at no more than 25 degrees C for up to 15 days. Custom research preparation: Use formulation-specific stability and microbiological controls rather than transferring the finished-product shelf life. Labeling: Record preparation date, final volume, concentration, vehicle, and storage conditions.

Side Effects

Safety observations

The 2008 comparative study reported similar anxiety-related effects for Selank and medazepam, with additional anti-asthenic and psychostimulant observations in the Selank group. In the 2012 GAD study, 40% of participants were classified as rapid responders during days 1 to 3, while 60% showed a gradual response pattern through day 14. The healthy-volunteer neuroimaging study examined functional connectivity after one intranasal Selank exposure rather than a repeated clinical course. The current manufacturer instruction lists unpleasant taste sensations and possible allergic reactions among reported adverse effects. Pump output, formulation, nasal condition, and administration technique can affect the delivered amount and deposition pattern.

Important Notes

Small measurement and device details can materially change the amount delivered per spray. Use a measured final volume, not the bottle capacity mark alone. Verify that the actuator releases 0.10 mL per full stroke before applying the main table. Prime and reprime exactly as specified for the pump, then record those actuations. Keep the bottle upright and use a complete, consistent stroke for each recorded spray. Treat the theoretical 50 or 100 sprays as nominal counts because priming and residual hold-up consume part of the volume. A 10 mg vial contains 10,000 mcg total. Calculate the complete peptide requirement before modeling any multi-day published protocol. Use a validated laboratory handling and stability plan for any custom multidose preparation.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps SK10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: SK10
  • Product: Selank 10mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 10mg x 10 vials / 10mg x 10 vials
  • Listed box price: $85.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is SK10?

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human studies have examined anxiety-related clinical measures, leu-enkephalin metabolism, EEG response patterns, and functional brain connectivity after Selank exposure. Intranasal drops or solution are the delivery methods reported in the primary human research summarized on this page. The vial calculation is concentration based. Dividing 10,000 mcg by the measured final volume gives mcg per mL. Multiplying that concentration by the verified pump output gives mcg per spray

Research context

5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Research

Reference literature focus

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human Selank research has primarily used the intranasal route. Quick reference for the intranasal Selank 10 mg calculation. Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Dosing & Protocol

LPPeptide handling reference

Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Storage

Registered 0.15% product: Protected from light, stored at no more than 10 degrees C, and not frozen. Opened registered product: The manufacturer permits storage at no more than 25 degrees C for up to 15 days. Custom research preparation: Use formulation-specific stability and microbiological controls rather than transferring the finished-product shelf life. Labeling: Record preparation date, final volume, concentration, vehicle, and storage conditions.

Side Effects

Safety observations

The 2008 comparative study reported similar anxiety-related effects for Selank and medazepam, with additional anti-asthenic and psychostimulant observations in the Selank group. In the 2012 GAD study, 40% of participants were classified as rapid responders during days 1 to 3, while 60% showed a gradual response pattern through day 14. The healthy-volunteer neuroimaging study examined functional connectivity after one intranasal Selank exposure rather than a repeated clinical course. The current manufacturer instruction lists unpleasant taste sensations and possible allergic reactions among reported adverse effects. Pump output, formulation, nasal condition, and administration technique can affect the delivered amount and deposition pattern.

Important Notes

Small measurement and device details can materially change the amount delivered per spray. Use a measured final volume, not the bottle capacity mark alone. Verify that the actuator releases 0.10 mL per full stroke before applying the main table. Prime and reprime exactly as specified for the pump, then record those actuations. Keep the bottle upright and use a complete, consistent stroke for each recorded spray. Treat the theoretical 50 or 100 sprays as nominal counts because priming and residual hold-up consume part of the volume. A 10 mg vial contains 10,000 mcg total. Calculate the complete peptide requirement before modeling any multi-day published protocol. Use a validated laboratory handling and stability plan for any custom multidose preparation.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps SK10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: SK10 - Product: Selank 10mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 10mg x 10 vials / 10mg x 10 vials - Listed box price: $85.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is SK10?

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human studies have examined anxiety-related clinical measures, leu-enkephalin metabolism, EEG response patterns, and functional brain connectivity after Selank exposure. Intranasal drops or solution are the delivery methods reported in the primary human research summarized on this page. The vial calculation is concentration based. Dividing 10,000 mcg by the measured final volume gives mcg per mL. Multiplying that concentration by the verified pump output gives mcg per spray

Research context

5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Research

Reference literature focus

Selank is a synthetic heptapeptide based on the tuftsin sequence. Human Selank research has primarily used the intranasal route. Quick reference for the intranasal Selank 10 mg calculation. Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Dosing & Protocol

LPPeptide handling reference

Human research route: Intranasal drops or solution. Peptide amount: 10,000 mcg total in the vial. 5 mL option: 2,000 mcg/mL and 200 mcg per verified 0.10 mL spray. 10 mL option: 1,000 mcg/mL and 100 mcg per verified 0.10 mL spray. Final-volume rule: Bring the transferred solution to an exact measured final volume.

Storage

Registered 0.15% product: Protected from light, stored at no more than 10 degrees C, and not frozen. Opened registered product: The manufacturer permits storage at no more than 25 degrees C for up to 15 days. Custom research preparation: Use formulation-specific stability and microbiological controls rather than transferring the finished-product shelf life. Labeling: Record preparation date, final volume, concentration, vehicle, and storage conditions.

Side Effects

Safety observations

The 2008 comparative study reported similar anxiety-related effects for Selank and medazepam, with additional anti-asthenic and psychostimulant observations in the Selank group. In the 2012 GAD study, 40% of participants were classified as rapid responders during days 1 to 3, while 60% showed a gradual response pattern through day 14. The healthy-volunteer neuroimaging study examined functional connectivity after one intranasal Selank exposure rather than a repeated clinical course. The current manufacturer instruction lists unpleasant taste sensations and possible allergic reactions among reported adverse effects. Pump output, formulation, nasal condition, and administration technique can affect the delivered amount and deposition pattern.

Important Notes

Small measurement and device details can materially change the amount delivered per spray. Use a measured final volume, not the bottle capacity mark alone. Verify that the actuator releases 0.10 mL per full stroke before applying the main table. Prime and reprime exactly as specified for the pump, then record those actuations. Keep the bottle upright and use a complete, consistent stroke for each recorded spray. Treat the theoretical 50 or 100 sprays as nominal counts because priming and residual hold-up consume part of the volume. A 10 mg vial contains 10,000 mcg total. Calculate the complete peptide requirement before modeling any multi-day published protocol. Use a validated laboratory handling and stability plan for any custom multidose preparation.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps SK10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: SK10 - Product: Selank 10mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 10mg x 10 vials / 10mg x 10 vials - Listed box price: $85.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.